Randomized trial demonstrates enhanced flap survival in ischemic conditions, suggesting a new therapeutic approach.
Multiterritory perforator flaps are widely used in reconstructive surgery; however, distal regions, particularly the choke zone, remain highly susceptible to necrosis due to sustained ischemia, oxidative stress, and endothelial inflammatory injury that impair microcirculatory remodeling. Although stem cell-derived exosomes are promising cell-free therapeutics, their efficacy in ischemic flaps is often limited by poor local retention and rapid loss of bioactivity. Here, we develop a bioadhesive antioxidant hydrogel composed of oxidized hyaluronic acid-dopamine and sericin methacrylate (SerMA) to enable stable wet-tissue adhesion and sustained local delivery of hypoxia-preconditioned adipose-derived stem cell exosomes. This strategy attenuates oxidative stress, suppresses NLRP3 inflammasome activation and endothelial pyroptosis, and preserves mitochondrial and angiogenic function under ischemic conditions. In a rat multiterritory perforator flap model, local application of the exosome-loaded hydrogel significantly enhanced flap perfusion and survival, promoted vascular remodeling within the choke zone, and reduced inflammatory responses. Transcriptomic analysis further revealed suppression of inflammasome-associated pathways and enrichment of vascular remodeling programs. Collectively, this work presents a bioadhesive hydrogel-based exosome delivery strategy that stabilizes the ischemic microenvironment and improves outcomes in complex perforator flap reconstruction.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: